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Intraoperative lavage cytologic analysis of surgical
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Background: One of the unfavorable recurrent patterns after limited
surgery for lung cancer is local failure, especially at the surgical margin
in the pulmonary parenchyma. To prevent this failure, we preliminarily
introduced a novel intraoperative lavage cytologic technique to check
surgical margin status for limited surgery. In this study we analyzed the
clinical utility of this technique with a larger number of patients under
long-term follow-up.
Methods: A total 112 consecutive lung cancer lesions prospectively
treated by limited surgery with the intraoperative lavage cytologic tech-
nique between October 1997 and August 2000 were reviewed through a
median follow-up period of 27 months.
Results: Eleven lesions (10%) showed cytologically positive results in
the attempted surgery on the surgical margin. The positive result rate was
significantly higher for lesions with more advanced stage, compromised
indication, incurability, and larger size. Surgical modes were converted intraoper-
atively for 4 lesions; in the other 7 lesions no conversion was performed because of
certain disadvantages. Local recurrence in the surgical margin occurred in a total of
4 lesions, including 3 for which the operative mode was unconverted and 1 lesion
with cytologically unknown status of the surgical margin that had the mode
converted, whereas there were no local recurrences in the surgical margins among
the lesions with final cytologically negative results.
Conclusion: Cytologically negative results of examination of the surgical margin by
the technique of intraoperative lavage cytologic in limited surgery for lung cancer
may be predict lack of local recurrence in the surgical margin. This intraoperative
cytologic technique is clinically useful in checking for complete resection of this
primary disease.
Although limited surgical procedures, such as segmentectomy,wide wedge resection (WWR) under open thoracotomy, and vid-eo-assisted thoracic surgery (VATS), have been more aggres-sively performed for small lung carcinoma, the risk for the tumorresidue in the pulmonary parenchyma of the surgical margin isgreater.1-8 In particular, when a tumor is very small (usually less
than 10 mm in diameter), a well-differentiated adenocarcinoma such as a bronchi-
oloalveolar type, type IV on Higashiyama’s classification,9 or the deep-seated type
within the pulmonary parenchyma beneath the pleura, its margin is often undeter-
mined during the operation.
To avoid this unfortunate local failure, we developed a novel checking test,
intraoperative lavage cytologic examination of the surgical margin, for limited
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surgery.10 Moreover, we recently reported that this checking
system is potentially useful to obtain complete local cure in
metastasectomy for pulmonary metastases.11
On the basis of our preliminary results,10 we prospec-
tively used this technique in limited surgery for lung cancer.
In this study, with a large number of patients under long-
term follow-up, we reviewed the clinical utility of this
technique as a predictor of local completeness in the surgi-
cal margin.
Patients and Methods
Between October 1997 and August 2000, limited surgery was
preoperatively scheduled for 110 consecutive patients with pri-
mary lung cancer comprising a total of 115 lesions in our institute
on the basis of the following two indications: intentional and
compromised cases. The former group, in which 60 lesions were
included, underwent limited surgery under the selected criterion of
peripheral small-sized clinical-stage IA lung cancer, as described
previously by Kodama and colleagues.1,4 Most patients whose
lesions were 20 mm or smaller and type III and IV adenocarci-
noma according to Higashiyama and associates’ classification9
were aggressively entered into this group. The latter group, in
which 55 lesions were included, principally underwent limited
resection because of preoperative high-risk complications, multi-
ple lung cancers, or advanced age. Of the lesions in this study, 59
lesions resected between October 1997 and March 1999 were
registered in our preliminary report.10 With regard to the clinical
stage of the latter group, 39 lesions were of stage IA, 9 were of
stage IB, 2 were of stage IIB, 3 were of stage IIIA, 1 was of stage
IIIB, and 1 was of stage IV because of brain metastasis. For 110
lesions limited surgery was attempted through thoracotomy,
whereas 5 lesions were resected with VATS. However, conversion
to standard surgery for lung cancer was performed in 3 lesions of
intentional indication because regional lymph node involvement
was detected during the operation. Therefore, excluding the pre-
viously mentioned 3 lesions in 3 patients, a total of 112 lesions in
107 patients with 57 intentional and 55 compromised indications
were analyzed in this study.
The patients, aged 34 to 84 years (mean 63.0 years), included
59 men and 48 women. Tumor size ranged from 0.5 to 5.5 cm
(median size 1.6 cm). Thirty-five lesions were 1 cm or smaller, 36
were between 1.1 cm and 2.0 cm, 28 were between 2.1 cm and 3.0
cm, and 13 were larger than 3.0 cm. Histologically, only 37 lesions
were preoperatively diagnosed as lung cancer. Finally, 91 lesions
were adenocarcinomas, 14 were squamous cell carcinomas, 4 were
large cell carcinomas, and 3 were other histologic types (2 small
cell lung cancers and 1 adenosquamous cell carcinoma).
The operative techniques of WWR (n  55), VATS-WWR
(n  5), and segmentectomy (n  52) have been previously
described elsewhere.1,4,8,12 We designated the method of wedge
resection with macroscopically greater safe margin than the tumor
diameter as WWR.8 Stapler, Nd:YAG laser, and electric scissors
were used to divide the pulmonary parenchyma with such a safe
margin. Pleural lavage cytologic examination was performed im-
mediately after thoracotomy to avoid tumor cell contamination on
the surgical margin in 97 lesions13 but was not done in the other 15
lesions because of severe pleural adhesion.
The lavage cytologic technique for the surgical margin, as
described previously, is as follows.10 Briefly, when limited surgery
Figure 1. Lavage cytologic technique of surgical margin in limited surgery for lung cancer. A, When limited surgery
was performed with stapler, its fired cartridges were collectively washed in saline solution for lavage cytologic
examination. B, When limited surgery was performed with Nd:YAG laser or electric scissors, alone or in
combination with stapler, specimen was washed without flooding of pleural surface in saline solution for lavage
cytologic examination.
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was performed with a stapler alone, all fired cartridges were
washed in 200 mL saline solution (Figure 1, A). When tumor
excision was performed with the Nd:YAG laser, electric scissors,
or a combination with a stapler, the resected specimens were
similarly washed without flooding of the pleural surface (Figure 1,
B). When tumors were resected with combined methods, both the
used cartridges and the resected samples were washed. These
lavage techniques were carefully performed with the avoidance of
tumor cell contamination from the pleural surface and were also
done before making cross-sections of the specimens.
After centrifugation, the sediment was immediately fixed with
Saccomanno solution and was then smeared on a glass slide by
Cytospin (Thermo Electron Corporation, Waltham, Mass). Then,
after final refixation with ethanol and diethyl ether, the sediment
was stained with the Papanicolaou method. The cytologic results
were judged as positive (Figure 2) or negative by a cytologist and
were then immediately reported to the operating room. It usually
took approximately 15 to 25 minutes for the completion of these
lavage cytologic examinations.
A total of 7 lesions showed incurability at the end of the
operation because of conventionally unfavorable findings as fol-
lows: tumor residue in the lymph nodes in 2 lesions, tumor residue
because of multiple lung cancer in 3 lesions, pleural dissemination
in 1 lesion, and brain metastasis in 1 lesion.
To check the surgical margin status in the enrolled lesions
undergoing limited surgery, postoperative follow-up examinations
were principally performed by plain chest roentgenography every
3 to 6 months and by computed tomographic scan every 6 to 12
months. Local recurrence in the surgical margin was diagnosed by
clinical course and laboratory data, especially focusing on abnor-
mal growing or regrowing shadows on computed tomographic
scan in the surgical margin area, namely involving the stapler line
within the pulmonary parenchyma. The median follow-up period
of the patients was 27 months, ranging from 5 to 47 months.
Counts were compared with the Fisher exact test.
Results
Association Between Positive Cytologic Result and
Clinicopathologic Factors in the Attempted Limited
Surgery
Of the lesions examined in this series, 11 lesions (10%) in
10 patients showed cytologically positive results (Figure 2)
in the surgical margin despite a macroscopically safe mar-
gin in the attempted limited surgery. Table 1 shows a
summary of the association between positive cytologic re-
sults and clinicopathologic factors. The positive result rate
was significantly associated with clinical stage, indication,
pathologic stage, and curability and was marginally signif-
icantly associated with tumor size. Its rate was higher for
lesions of more advanced clinical stage (clinical stage IB, II,
III, and IV vs clinical stage IA P  .002) and pathologic
stage (pathologic stage IB, II, III, and IV vs pathologic stage
IA P  .001), those with compromised indications (com-
promised vs intentional P .003), incurability (noncurative
vs curative P  .001), and larger tumor size (2.0 cm vs
2.0 cm P  .050). There was no association between
positive cytologic result and surgical method, dividing tech-
nique, or histologic type.
Figure 2. Representative cytologically positive specimens by lavage cytologic technique of surgical margin in
limited surgery for lung cancer. A, Adenocarcinoma. B, Squamous cell carcinoma.
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Intraoperative Conversion of Surgical Mode for
Lesions with Cytologically Positive Results (Table 2)
For 4 lesions with cytologically positive results, intraoper-
ative conversion of the surgical mode was performed. For 1
lesion with intentional indication (lesion 1), completion
lower lobe lobectomy was immediately performed. Com-
pletion middle lobe lobectomy was carefully done for 1
lesion with compromised indication because of low respi-
ratory function resulting from a severe tuberculosis scar
(lesion 2). Completion segmentectomy was additionally
performed for 1 lesion (lesion 3) undergoing WWR, and a
cytologically negative result in the new margin area was
finally obtained. Additional evaporation with the Nd:YAG
laser on the surgical margin was narrowly done for 1 lesion
(lesion 4) undergoing segmentectomy because of a compro-
mised indication related to severely poor respiratory func-
tion, but the final cytologic status of the new margin re-
mained undetermined. On the other hand, no additional
resection was performed for the other 7 lesions with positive
results because of compromised indications related to car-
diopulmonary disease in 1 lesion (lesion 5), tumor burden
status of another organ origin in 1 lesion (lesion 6), multiple
lung cancer in 3 lesions (lesions 7-9), and noncurative
reasons in 2 lesions (lesions 10 and 11).
Final Surgical Mode and Postoperative Results in the
Surgical Margin
Of the enrolled lesions, 2 (lesions 1 and 2) were finally
resected by completion lobectomy, and in addition 1 lesion,
despite a cytologically negative result in the margin, was
also consequently resected by completion lobectomy be-
cause of an incidental benign lesion within the same lobe.
Thus 109 lesions were resected by limited surgical mode,
including 101 lesions with final cytologically negative re-
sults, 7 lesions left with cytologically positive results (le-
sions 5-11), and 1 lesion with final cytologic status unde-
termined (lesion 4).
During the follow-up period, local recurrence in the
surgical margin occurred in a total of 4 lesions, including 3
cytologically positive lesions for which the mode was un-
converted (lesions 8-10) and 1 lesion that was cytologically
undetermined after further evaporation (lesion 4). Despite
intraoperative Nd:YAG laser evaporation treatment against
the cytologically positive surgical margin, the lesion 4 re-
curred in this area 25 months after the operation. The patient
with lesion 7 died of bone metastases with no evidence of
local recurrence in the surgical margin 13 months after the
operation. The follow-up data for the patient with lesion 10
were lost 5 months after the operation because the patient
moved away. In contrast, there were no local recurrences in
the surgical margin area among the patients with cytologi-
cally negative results. These results are summarized in
Figure 3.
Discussion
Along with the recent dramatic increase in relatively smaller
sized lung cancer or early lung cancer with clinical staging
of T1 N0,1,4,6-9,14 there has been more opportunity for lim-
ited surgery for this disease with not only compromised but
also intentional indications. In prospectively attempting this
surgical mode, however, stricter intraoperative evaluation of
the following two problems of local curability may be
required: nodal metastasis and complete resection of the
primary lesion. To overcome the former problem, node
dissection or sampling should be selectively and carefully
performed.1,4,6,7 On the other hand, a checking test for local
completeness of the primary lesion has not been practically
satisfactory.
Usually, limited surgery should be performed while
maintaining a macroscopically safe surgical margin. In our
TABLE 1. Summary of positive cytologic results and clini-
copathologic factors
Tested lesions (No.)
Positive
results
No. %
Total 112 11 10
Tumor size (mm)*
1.0 35 1 3
1.1-2.0 36 3 8
2.1-3.0 28 4 14
3.1 13 3 23
Clinical stage†
IA 96 6 6
IB 9 3 33
II, III, IV 7 2 29
Indication†
Intentional 57 1 2
Compromised 55 10 18
Attempted surgery
WWR 55 8 15
VATS-WWR 5 0 0
Segmentectomy 52 3 6
Cutting technique
Stapler 54 6 11
Nd: YAG laser 24 3 13
Electric
scissors
9 0 0
Combination 25 2 8
Pathologic stage†
IA 93 4 4
IB 15 5 33
II, III, IV 4 2 50
Curability†
Curative 105 7 7
Noncurative 7 4 57
Histologic type
Adenocarcinoma 91 7 8
Nonadenocarcinoma 21 4 19
*Marginally significant.
†Significant.
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institute, tumors were resected in keeping with this princi-
ple: more than 2 cm if possible, or at least with a safe
margin greater than the lesion diameter under the deflating
condition of the lung.1,4,8 Because the resected line of lim-
ited surgery did not always maintain such a distance, how-
ever, for example because of anatomic, physiologic, his-
topathologic, or technical conditions, we developed a
cutting technique with the Nd:YAG laser, if necessary in
combination with a stapler.1,4,9,12 In addition, conventional
frozen-section histologic examination for checking the sur-
gical margin was aggressively performed. However, this
intraoperative examination was often not technically com-
plete enough for an accurate diagnosis, for example when a
stapler was used, when the cutting surface was too wide, or
when the resected specimens were too supple. To address
this problem, intraoperative stamped cytologic examination
to the surface of surgical margin was introduced,15 but the
whole area of the resected margin could not be perfectly
checked. In contrast, this novel technique of checking for
residual tumor cells in the surgical margin offers more
advantages. During the operation, the whole area of the
margins can be collectively examined. If necessary each
margin can be separately tested in a relatively short time,
and any aspects of the surgical margin by any dividing
method can be examined, whether with open thoracotomy
or with VATS. On the basis of this background, we devel-
oped this system for limited surgery.10 In this study, its
surgical results were analyzed on a large scale.
The rate of positive cytologic results in the surgical
margin at the attempted limited surgery was unexpectedly
high (11%), almost the same as preliminarily reported.10
However, considering that this rate was closely associated
with stage, indication, curability, and tumor size, limited
surgery with intentional indication for stage I lung cancer of
smaller size has been almost safe in terms of complete
resection, suggesting that this test appears unnecessary un-
der such favorable conditions. Nevertheless, in practice it is
better to confirm local completeness by this technique in-
traoperatively, because local failure associated with limited
surgery with only an intentional indication may not be
TABLE 2. Intraoperative conversion of surgical mode for lung cancer lesions with cytologically positive results
Lesion
No. Disease
Clinical
stage
Tumor
size
(mm) Indication
Attempted surgery
and cutting
technique Conversion
Pathologic
stage Follow-up
Recurrence
in surgical
margin
1 Adeno-
carcinoma
T1 N0 17 Intentional WWR, Nd:YAG
laser
Completion
lobectomy
T1 N0 Alive without return
or recurrence, 37
mo
2 Squamous
cell
carcinoma
T2 N0 34 Compromised WWR, stapler Completion
lobectomy
T2 N0 Alive without return
or recurrence, 18
mo
3 Adeno-
carcinoma
T1 N0 20 Compromised WWR, stapler Completion
segmentectomy
T1 N0 Alive without return
or recurrence, 16
mo
No
4 Adeno-
carcinoma
T1 N0 28 Compromised Segmentectomy,
Nd:YAG laser
Additional
evaporation
T1 N0 Alive with tumor
recurrence, 28
mo
Yes
5 Squamous
cell
carcinoma
T2 N0 33 Compromised WWR, stapler No (cardiopulmonary
disease)
T2 N0 Alive with tumor
recurrence, 30
mo
No
6 Large cell
carcinoma
T2 N2 22 Compromised Segmentectomy,
stapler
No (tumor-burden
status)
T2 N0 P2 Alive without return
or recurrence, 42
mo
No
7 Adeno-
carcinoma
T1 N0 25 Compromised Segmentectomy,
stapler plus
Nd:YAG laser
No (multiple lung
cancers,
noncurative)
T2 N0 Death, 13 mo No
8,9 Adeno-
carcinoma
T2 N0,
T1 N0
40,
10
Compromised WWR, WWR,
Nd:YAG laser,
stapler plus
Nd:YAG laser
No (multiple lung
cancers,
noncurative)
T2 N0,
T1 N0
Alive with tumor
recurrence, 31
mo
Yes, Yes
10 Adeno-
carcinoma
T1 N0 17 Compromised WWR, stapler No (node residue,
noncurative)
T1 N2 Alive with tumor
recurrence, 29
mo
Yes
11 Small cell
carcinoma
T3 N0 30 Compromised WWR, stapler No (dissemination,
noncurative)
T4 N2 Alive with tumor
recurrence, 5 mo
Unknown
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permitted. In particular, considering the data by Sawabata
and associates,15 this technique should be performed espe-
cially in cases with a smaller safe margin than 1 cm.
As also was previously reported,10 when cytologically
positive results in intentional limited surgery are obtained
by this technique, the surgical mode should be immediately
converted to standard resection. In fact, we have seen only
1 case with such a lesion (lesion 1). Even in such a case of
compromised limited surgery, additional resection should
be selectively performed if possible. In this series comple-
tion segmentectomy was performed for 1 lesion (lesion 3),
and completion middle lobe lobectomy was successfully
performed for 1 lesion (lesion 2), despite low respiratory
function. On the other hand, additional evaporation of the
margin with electric scissors or Nd:YAG laser is a modality
used as a salvage for potential curability. In fact, we con-
ducted this additional therapeutic modality for 1 lesion
(lesion 4), unfortunately with local failure. Recently we
reported a case with such a local recurrence after evapora-
tion by Nd:YAG laser in metastasectomy for pulmonary
metastasis from colorectal cancer.11 At present it is techni-
cally impossible to examine tumor residue in the final
surgical margin after the evaporation. Thus this technique
must be improved in the future.
To date a total of 4 lesions in this series, including 3 with
cytologically tumor-positive status and 1 with unknown
status in the surgical margin, have shown recurrence at the
surgical margin. In contrast, there have been no local recur-
rences in the surgical margin in cytologically tumor-nega-
tive lesions. Thus cytologically negative results by this
lavage cytologic technique may yield promising informa-
tion for complete local curability with limited surgery for
lung cancer. Similar data were also obtained for metasta-
sectomy for pulmonary metastases from various organs.11
Even if a tumor has such unfavorable factors as deep-seated
location and poorly defined tumor margin, we may be
encouraged to more completely attempt limited surgery
with this checking test.
In the previous series of limited surgery with 63 lung
cancer lesions between January 1985 and September 1996,
we reported that 1 patient (2%) undergoing compromised
limited surgery had recurrence in the surgical margin.4
Among 33 patients undergoing limited surgery between
October 1996 and November 1997, we saw such local
Figure 3. Scheme of surgical results of limited surgery according to cytologic status in surgical margin. There were
no local recurrences in surgical margins of lesions with cytologically negative results, whereas there was local
recurrence in 4 other lesions, including 3 cytologically positive lesions for which surgical mode was not converted
and 1 lesion that was cytologically undetermined after additional evaporation.
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failure in 2 cases, 1 each in the intentional and compromised
indication groups, with the rate as great as 6% (data not
shown). Surprisingly, Yano and associates2 reported that
recurrence in the surgical margin occurred at a rate of 24%
among compromised patients undergoing limited surgery.
In addition, although various types of locoregional recur-
rence were collectively analyzed, rates were 9.5%,16 17%,17
and 23%18 among the patients undergoing intentional lim-
ited surgery. In this series among 112 lesions after this novel
checking system, 4 lesions recurred in the surgical margin,
for a rate of about 4%. The rate dropped to zero (0%) when
limited to intentionally indicated lesions, and importantly
was also zero for finally cytologically negative confirmed
lesions. Among the 105 potentially curatively resected le-
sions, only 1 lesion (1%) showed local recurrence. Thus,
along with the recent increasing chance of limited surgery,
local curability has been more complete.
This intraoperative lavage cytologic technique is a prom-
ising tool for predicting local recurrence in the surgical
margin area of limited surgery for lung cancer. In promoting
limited surgery for lung cancer, it is necessary to examine
whether the tumor remains by using this technique for
checking the surgical margin status. Cytologically negative
results in the surgical margin may be a promising indicator
against local failure. When a cytologically positive result is
obtained, the surgical mode should be changed if possible.
We thank Jun-ichi Ashimura, CT, Sachiko Nagumo, CT, and
Yasuyoshi Naruse, CT, for their technical assistance in performing
cytologic analyses.
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